Clinical trial · Interventional
Preoperative Embolization in Surgical Treatment of Spinal Metastases.
Preoperative Embolization in Surgical Treatment of Spinal Metastases. A Randomized Controlled Trial.
NCT01365715CI-TRIAL-00013881completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main purpose of this study is to assess the efficacy of preoperative embolization in decreasing operative blood loss, decreasing the need for intraoperative transfusion and facilitate surgical resection in metastatic spine surgery. Furthermore the study aims at describing the vascularity in a series of spinal metastasis, and to correlate this with perioperative blood loss.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Spinal Metastases | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Arteriography | Procedure | — | UNRESOLVED |
| Arteriography and preoperative embolization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Preoperative embolization
- description
- 32 patients with spinal metastasis/metastases will undergo arteriography and receive transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.
- interventionNames
- Procedure: Arteriography and preoperative embolization
- type
- ACTIVE_COMPARATOR
- label
- Control group
- description
- 32 patients with spinal metastasis/metastases will undergo arteriography of spinal metastasis/metastases without receiving transcatheter arterial embolization prior to surgery.
- interventionNames
- Procedure: Arteriography
Primary outcomes (1)
- measure
- Perioperative blood loss
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients scheduled for decompression and posterior thoracic and/or lumbar instrumented spinal fusion because of spinal metastasis/metastases. * Informed signed consent. Exclusion Criteria: * Contrast fluid allergy. * Clotting disorders. * Renal failure. * Not suitable for arterial access. * Pregnancy.
References
Publications (0)
Data not yet available
No reference posted for this study.